These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 17888748)
1. Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization. Nordstrom SM; Carleton SM; Carson WL; Eren M; Phillips CL; Vaughan DE Bone; 2007 Dec; 41(6):995-1004. PubMed ID: 17888748 [TBL] [Abstract][Full Text] [Related]
2. Mice lacking the plasminogen activator inhibitor 1 are protected from trabecular bone loss induced by estrogen deficiency. Daci E; Verstuyf A; Moermans K; Bouillon R; Carmeliet G J Bone Miner Res; 2000 Aug; 15(8):1510-6. PubMed ID: 10934649 [TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 deficiency ameliorates insulin resistance and hyperlipidemia but not bone loss in obese female mice. Tamura Y; Kawao N; Yano M; Okada K; Matsuo O; Kaji H Endocrinology; 2014 May; 155(5):1708-17. PubMed ID: 24605827 [TBL] [Abstract][Full Text] [Related]
4. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice. Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339 [TBL] [Abstract][Full Text] [Related]
5. Reactive site-dependent phenotypic alterations in plasminogen activator inhibitor-1 transgenic mice. Eren M; Gleaves LA; Atkinson JB; King LE; Declerck PJ; Vaughan DE J Thromb Haemost; 2007 Jul; 5(7):1500-8. PubMed ID: 17439629 [TBL] [Abstract][Full Text] [Related]
6. Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength. Lim SV; Marenzana M; Hopkinson M; List EO; Kopchick JJ; Pereira M; Javaheri B; Roux JP; Chavassieux P; Korbonits M; Chenu C Endocrinology; 2015 Apr; 156(4):1362-71. PubMed ID: 25646711 [TBL] [Abstract][Full Text] [Related]
7. Fracture healing in mice deficient in plasminogen activator inhibitor-1. Rundle CH; Wang X; Wergedal JE; Mohan S; Lau KH Calcif Tissue Int; 2008 Oct; 83(4):276-84. PubMed ID: 18820962 [TBL] [Abstract][Full Text] [Related]
8. CART deficiency increases body weight but does not alter bone strength. Bartell SM; Isales CM; Baile CA; Kuhar MJ; Hamrick MW J Musculoskelet Neuronal Interact; 2008; 8(2):146-53. PubMed ID: 18622083 [TBL] [Abstract][Full Text] [Related]
9. Gender specific LRP5 influences on trabecular bone structure and strength. Dubrow SA; Hruby PM; Akhter MP J Musculoskelet Neuronal Interact; 2007; 7(2):166-73. PubMed ID: 17627087 [TBL] [Abstract][Full Text] [Related]
10. Bone resorption induced by 1 alpha,25 dihydroxyvitamin D(3) in vivo is not altered by inactivation of the plasminogen activator inhibitor 1. Daci E; Verstuyf A; Moermans K; Bouillon R; Carmeliet G Bone; 2000 Jul; 27(1):97-102. PubMed ID: 10865215 [TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 and vitronectin expression level and stoichiometry regulate vascular smooth muscle cell migration through physiological collagen matrices. Garg N; Goyal N; Strawn TL; Wu J; Mann KM; Lawrence DA; Fay WP J Thromb Haemost; 2010 Aug; 8(8):1847-54. PubMed ID: 20492459 [TBL] [Abstract][Full Text] [Related]
12. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. Glatt V; Canalis E; Stadmeyer L; Bouxsein ML J Bone Miner Res; 2007 Aug; 22(8):1197-207. PubMed ID: 17488199 [TBL] [Abstract][Full Text] [Related]
13. Exercise-induced changes in the cortical bone of growing mice are bone- and gender-specific. Wallace JM; Rajachar RM; Allen MR; Bloomfield SA; Robey PG; Young MF; Kohn DH Bone; 2007 Apr; 40(4):1120-7. PubMed ID: 17240210 [TBL] [Abstract][Full Text] [Related]
14. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014 [TBL] [Abstract][Full Text] [Related]
15. Disruption of aldehyde dehydrogenase 2 gene results in altered cortical bone structure and increased cortical bone mineral density in the femoral diaphysis of mice. Tsuchiya T; Sakai A; Menuki K; Mori T; Takeuchi Y; Kanoh S; Utsunomiya H; Murai T; Isse T; Kawamoto T; Nakamura T Bone; 2013 Apr; 53(2):358-68. PubMed ID: 23313283 [TBL] [Abstract][Full Text] [Related]
16. Unmasking the osteoinductive effects of a G-protein-coupled receptor (GPCR) kinase (GRK) inhibitor by treatment with PTH(1-34). Wang L; Quarles LD; Spurney RF J Bone Miner Res; 2004 Oct; 19(10):1661-70. PubMed ID: 15355561 [TBL] [Abstract][Full Text] [Related]
17. The effect of androstenedione/estrone supplementation on cortical and cancellous bone in the young intact female monkey: a model for the effects of polycystic ovarian disease on the skeleton? Lundon KM; Jayo MJ; Register TC; Dumitriu M; Grynpas MD Osteoporos Int; 2000; 11(9):778-89. PubMed ID: 11210841 [TBL] [Abstract][Full Text] [Related]
18. High bone mass in mice expressing a mutant LRP5 gene. Babij P; Zhao W; Small C; Kharode Y; Yaworsky PJ; Bouxsein ML; Reddy PS; Bodine PV; Robinson JA; Bhat B; Marzolf J; Moran RA; Bex F J Bone Miner Res; 2003 Jun; 18(6):960-74. PubMed ID: 12817748 [TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease. Lassila M; Fukami K; Jandeleit-Dahm K; Semple T; Carmeliet P; Cooper ME; Kitching AR Diabetologia; 2007 Jun; 50(6):1315-26. PubMed ID: 17415547 [TBL] [Abstract][Full Text] [Related]
20. Age and ovariectomy impair both the normalization of mechanical properties and the accretion of mineral by the fracture callus in rats. Meyer RA; Tsahakis PJ; Martin DF; Banks DM; Harrow ME; Kiebzak GM J Orthop Res; 2001 May; 19(3):428-35. PubMed ID: 11398856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]